July 2, 2021 11:10 AM EDT

Sartorius buys majority stake in German manufacturing player; Cerevel Therapeutics ends the week on a high note, with $350M raise

Sartorius Stedim Biotech acquired a majority stake in Germany-based CellGenix GmbH, the companies announced Friday.

Sartorius has acquired 51% of the …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Sar­to­rius buys ma­jor­i­ty stake in Ger­man man­u­fac­tur­ing play­er; Cerev­el Ther­a­peu­tics ends the week on a high note, with $350M raise